MedPath

Benztropine Mesylate

Benztropine Mesylate Injection, USP

Approved
Approval ID

d61eae0d-a29d-45ef-bd41-07123e0c21f9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 31, 2013

Manufacturers
FDA

TYA Pharmaceuticals

DUNS: 938389038

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Benztropine Mesylate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64725-0012
Application NumberNDA012015
Product Classification
M
Marketing Category
C73605
G
Generic Name
Benztropine Mesylate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateAugust 10, 2012
FDA Product Classification

INGREDIENTS (3)

Benztropine MesylateActive
Quantity: 1 mg in 1 mL
Code: WMJ8TL7510
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Benztropine Mesylate - FDA Drug Approval Details